ITMCTR1900002639招募中未知
A multicenter randomized controlled trial of Qingre Liangxue therapy for psoriasis blood-heat syndrome
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •1. Western diagnostic criteria and diagnostic criteria for TCM syndromes that meet psoriasis;
- •2. Skin lesions involve <=10% BSA (the lesions are mainly located in the trunk and / or limbs, palm / sole, face / scalp, vulva area is not included);
- •3. Age between 18 and 65 years old;
- •4. Those who voluntarily participate in the study and sign the informed consent form.
排除标准
- •1. Erythrodermic, arthritic, pustular psoriasis patients;
- •2. There are other active skin diseases that may affect the condition assessment;
- •3. Systematic treatment of research drugs, biological agents and immunosuppressive agents within 1 month;
- •4. Within 2 weeks, he received treatment with topical glucocorticoids, phototherapy, etc.;
- •5. During severe, uncontrollable local or systemic acute or chronic infections;
- •7. Patients with severe systemic diseases; or clinical test indicators in one of the following conditions: alanine aminotransferase or aspartate aminotransferase increased by >1.5 times the upper limit of normal; creatinine increased by 1.5 times the upper limit of normal; main indicators of blood routine ( Any one of the white blood cell count, red blood cell count, hemoglobin amount, and platelet count) is below the lower limit of normal; or other laboratory abnormalities are judged by the investigator to be unsuitable for participation in the trial;
- •8. Patients with a history of malignant tumors and primary or secondary immunodeficiency and hypersensitivity patients;
- •9. Those who have participated in other drug clinical trials within 3 months;
- •10. Such surgery will be required during major surgery or study within 8 weeks;
- •11. For women of childbearing age who have fertility, no effective contraceptive measures have been taken from the screening period until the end of the last dose;
- •12. Pregnant or lactating women;
- •13. Those who have a history of alcohol abuse, drug abuse or drug abuse;
- •14. Those with a history of serious mental illness or family history;
- •15. The investigator considered it inappropriate to participate in the study.
研究者
相似试验
尚未招募
1 期
A multicenter, randomized, controlled trial of Qingyu Powder in the treatment of mild to moderate active ulcerative colitisulcerative colitisITMCTR2000003558Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine
尚未招募
2 期
A randomized controlled clinical Trial for Qingre Huayu Formula on left ventricular remodeling in patients with ST segment elevation myocardial infarctioST segment elevation myocardial infarctionITMCTR2000003834Shuguang Hospital of Shanghai University of Traditional Chinese
尚未招募
3 期
The multicenter randomized controlled study for Qihuang yishen granule improve proteinuria of diabetic kidney diseaseDiabetic kidney diseaseITMCTR1900002263Wangjing Hospital, China Academy of Chinese Medical Sciences
尚未招募
1 期
A random, multi-center controlled trial for Qi-Jing Hui-Xin Decoction in the treatment of microvascular anginamicrovascular anginaITMCTR1900002719Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
进行中（未招募）
3 期
Trial of sertraline to prevent post-traumatic brain injury depressioDepressive disorder after traumatic brain injuryMental and Behavioural DisordersISRCTN17518945King's College Hospital514